Boston Scientific To Study Complex DES Use; Taxus Complaints Surface
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is maintaining a "sober" outlook regarding its chances of obtaining increased reimbursement in the near-term for multi-vessel interventions using drug-eluting stents